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OBJECTIVES: To determine the presence of immunoglobulin E-rheumatoid factor in patients with juvenile rheumatoid
arthritis and to correlate it with clinical and laboratory parameters.
METHODS: A multicenter prospective study was carried out from January 1993 to January 1999 with the enrollment
of 3 centers of pediatric rheumatology. Ninety-one children with juvenile rheumatoid arthritis diagnosed according to the
American College of Rheumatology criteria were studied: 38 (42%) with systemic, 28 (31%) with pauciarticular, and 25
(27%) with polyarticular onset. Ages ranged from 2.1 years to 22.6 years (mean 10.5 ± 4.7), with 59 (65%) girls. The control
group consisted of 45 healthy children. The detection of immunoglobulin E-rheumatoid factor was carried out utilizing an
enzyme-linked immunosorbent assay. Associations of immunoglobulin E-rheumatoid factor with immunoglobulin M-
rheumatoid factor (latex agglutination test), total serum immunoglobulin E, erythrocyte sedimentation rate, antinuclear
antibody, and functional and radiological classes III or IV were analyzed.
RESULTS: Positive immunoglobulin E-rheumatoid factor was found in 15 (16.5%) of the 91 children with juvenile
rheumatoid arthritis: 7 (18.5%) with systemic, 5 (18%) with pauciarticular, and 3 (12%) with polyarticular onset. A significant
correlation was observed between immunoglobulin E-rheumatoid factor and total serum immunoglobulin E in the juvenile
rheumatoid arthritis patients. No correlation was found between immunoglobulin E-rheumatoid factor and positive latex
agglutination slide test, erythrocyte sedimentation rate, antinuclear antibody, or the functional and radiological classes III
or IV in any disease onset group. In 4 out of 45 control children (8.9%), immunoglobulin E-rheumatoid factor was positive
but with no correlation with total serum immunoglobulin E levels.
CONCLUSIONS: Immunoglobulin E-rheumatoid factor could be detected in 16.5% of juvenile rheumatoid arthritis
patients, particularly in those with high levels of total serum immunoglobulin E, and immunoglobulin E-rheumatoid factor
appears not to be associated with disease activity or severity.
DESCRIPTORS:  Rheumatoid factor. Immunoglobulin E.  Juvenile rheumatoid arthritis.  ELISA.
INTRODUCTION
Rheumatoid factors (RF) are spe-
cific autoantibodies directed against
antigenic determinants on the Fc frag-
ment of the IgG molecule1. However,
RFs are not unique to rheumatoid ar-
thritis; they sometimes occur in nor-
mal elderly individuals, healthy immu-
nized individuals, and patients with
other autoimmune diseases or chronic
infections2. Several studies have
shown that only 5% to 25% of chil-
dren with juvenile rheumatoid arthri-
tis (JRA) have positive latex aggluti-
nation tests for RF3.
RFs of the IgM immunoglobulin
class can be detected by employing
the commonly used agglutination test.
These antibodies directed to IgG are
the “classic” RFs that are associated
with adult-onset rheumatoid arthritis.
They are found in only a small sub-
group of children who have RF-posi-
tive polyarthritis, the disease that is
probably the childhood equivalent of
classic adult rheumatoid arthritis4.
3095.p65 30/10/02, 10:45209
210
REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(5):209-216, 2002 SEPTEMBER-OCTOBER
Children with JRA who are RF posi-
tive are likely to be girls, to be older at
disease onset, and to have many joints
involved. It has been suggested that
they have more roentgenographic evi-
dence of bony erosion and an overall
poorer prognosis than their rheumatoid
factor-negative counterparts5. Some
clinical and immunogenetic associa-
tions are well known, such as nodes,
bony erosions, functional incapacities,
and HLA Dw4  (DRB1*0401) and
Dw14 (BRB1*0404) associations5,6.
In one-third of patients with JRA
who present idiotypic expression with
cross-reaction for RF, classical RF
(IgM-RF) is not observed7. It is possi-
ble that in this group of patients, other
RF isotypes are present8. With the use
of ELISA, an increased detection is
observed in JRA, with IgM-RF being
demonstrated in 22% to 35% of pa-
tients, IgG-RF in 4% to 6%, and IgA-
RF in 30% to 60%, depending on the
type of disease onset9-11. The presence
of IgA-RF and IgM-RF has been ob-
served in a varying percentage of chil-
dren with JRA, mainly in the polyar-
ticular onset type12,13. However, the fre-
quency and clinical and prognostic
roles of the other RF isotypes (IgG and
IgE) in JRA are still unknown14.
There is evidence suggesting that
IgE-RF is associated with extra-articu-
lar rheumatoid vasculitis and activity
of the disease in rheumatoid arthri-
tis15,16. We found 1 study about IgE-RF
in JRA in the literature17. These inves-
tigators observed that sera from 11/26
children with JRA had low concentra-
tions of IgE-RF detected by the indi-
rect immunofluorescence technique
and suggested that IgE-RF may be in-
volved in the pathogenesis of JRA and
rheumatoid arthritis by eliciting type
I and III reactions17.
The aims of the present study were
to determine the presence and the lev-
els of IgE rheumatoid factor (IgE-RF)
in children with JRA and to correlate
its presence with sex, age at onset, dis-
ease duration, activity of disease,
erythrocyte sedimentation rate, antinu-
clear antibody, total serum IgE, IgM-
RF (latex agglutination), and func-
tional and radiological classes III or IV.
PATIENTS  AND  METHODS
Patients
A prospective, multicentric study
was carried out from January 1993 to
January 1999. Ninety-one children (59
girls) with JRA diagnosed according to
the American College of Rheumatol-
ogy criteria18,6 were studied. Sera were
randomly obtained from patients who
visited one of the following three
Centers of Pediatric Rheumatology:
Hospital de Clínicas da Universidade
de São Paulo, São Paulo (51 cases),
Hospital de Clínicas da Faculdade de
Medicina de Ribeirão Preto da
Universidade de São Paulo, Ribeirão
Preto, São Paulo (28 cases), and Hos-
pital de Clínicas da Universidade Fed-
eral de Uberlândia, Minas Gerais (12
cases). The age of the patients ranged
from 2.1 to 22.7 years (mean 10.5 ±
4.7). The type of disease onset was sys-
temic in 38 children, pauciarticular in
28, and polyarticular in 25.
Forty-five healthy control children
with no symptoms of connective tis-
sue disease or acute or chronic infec-
tions were selected from the pediatric
outpatient clinic. The mean age of
controls was 5.5 ± 3.3 years.
Inclusion criteria
All patients included had no clini-
cal symptoms suggestive of allergic
rhynitis, asthma, or atopic dermatitis.
In addition, they had 3 samples of
feces examined for helminths with
negative results. None of the JRA pa-
tients were receiving or had received
gold salts or D-penicilamine.
METHODS
Serum was obtained from each pa-
tient during the first appointment after
obtaining fully informed consent from
their parents or relatives. Approval for
the study was also obtained from the 3
Institutional Ethics Committees. Serum
samples were stored at –20°C.
The demographic and clinical char-
acteristics of the JRA patients are
shown in table 1 (sex, age at onset, dis-
ease duration, and activity of disease).
Serum was obtained from each patient
for the following laboratory measure-
ments: erythrocyte sedimentation rate
(by the Wyntrobe method), antinuclear
antibody (by the Hep 2 immunoassay
method), and total serum IgE (measured
by monoclonal antibody-based ELISA
modified from a previously described
radioimmunoassay (RIA) by Pollart19).
Values of total IgE ≥ 300 IU/mL were
considered abnormally high (posi-
tive)20. IgM-RF was determined by the
latex agglutination slide test using a
commercially available kit (RapiTex
RF, Hoechst, Marburg, Germany). Sam-
ples with RF of 20 IU/mL or more were
considered to be positive.
Active disease was defined by the
presence of joint swelling or limitation
of mobility with warmth, pain, or ten-
derness in 1 or more joints. Severity
was evaluated according to
Steinbrocker’s functional and radio-
logical classes21with classes III and IV
denoting major dysfunction.
Quantitative determination of the
IGE rheumatoid factor by ELISA
IgE-RF was determined by a stand-
ard ELISA technique according to
SILVA22, with some modifications. The
samples were always analyzed in du-
plicate.
Briefly, polystyrene microtiter
plates were coated with 10 µg/mL of
mouse IgG in 0.06 M carbonate buffer,
pH 9.6, overnight at 4ºC. Plates were
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washed in 0.01M phosphate buffered
saline (PBS), pH 7.2, containing
0.05% Tween 20 (PBS-T) and blocked
with PBS-T plus 1% bovine serum al-
bumin (PBS-T-BSA) for 1 h at room
temperature (RT). Washings in PBS-T
were done between the steps of the re-
action. The plates were incubated with
serum samples diluted 1:5 in PBS-T, in
duplicate, for 1 h at RT. Subsequently,
peroxidase-rabbit IgG anti-human IgE,
prepared as described by Wilson and
Nakane23, at 1:500 in PBS-T was added
and incubated for 1 h at RT.  Finally,
enzymatic substrate consisting of
0.03% H2O2 and ortho-phenylenedi-
amine in 0.1 M phosphate citrate
buffer, pH 5.0, was added and incu-
bated for 15 min at RT. Adding 2 N
H2SO4 stopped the reaction, and the
absorbancy was read at 492 nm in a
plate reader (Titertek Multiskan, Flow
Laboratories, USA). Two positive and
10 negative control sera were included
in each assay. Positive sera were ob-
tained from patients who had IgM-RF
by the latex agglutination test and
IgE-RF by previous ELISA tests in the
standardization of the assays. Negative
sera were obtained from healthy chil-
dren.
The results were expressed as
ELISA index (EI) and calculated as
follows: EI  =  absorbancy of serum
samples / cut off, where cut off was de-
termined as the mean absorbancy of
the negative control serum plus 3
standard deviations. Samples present-
ing EI values > 1 were considered posi-
tive.
STATISTICS
Statistical analysis consisted of
determinations of geometric means
with 95% confidence intervals (CI) for
measurements of total serum IgE.
Comparisons between the ages of chil-
dren with JRA were performed using
the Student t test. This test was also
used to compare the geometric means
of total serum IgE. The positive and
negative samples were listed in contin-
gency tables and analyzed by the χ2
and Fisher exact tests24. Significance
was accepted when P <0.05. Statisti-
cal calculations were performed using
a standard Statistical Package Social
Science (SPSS) program.
RESULTS
IgE-RF was detected in 15/91
(16.5%) patients with JRA and 4/45
(8.9%) children from the control group
(P >0.05) (Fig. 1A). Disease onset was
systemic in 7 (18.4%), pauciarticular
in 5 (17.8%), and polyarticular in 3
(12%) (Fig.1B).
An attempt was made to compare
IgE-RF-positive and negative patients
in the JRA groups. Comparisons of the
most significant clinical features be-
tween the groups (with or without IgE-
RF) are shown in table 2. There was no
significant difference between the
clinical and laboratory factors (disease
activity, erythrocyte sedimentation
rate, antinuclear antibody, or functional
and radiological class III or IV) and
the presence or not of the IgE-RF, ex-
cept for the log of geometric mean of
the total serum IgE, which was signifi-
cantly higher (P = 0.03) in the group
of patients with positive IgE-RF (Ta-
ble 2).
The presence or absence of IgE-RF
in sera from JRA patients and control
children was analyzed in comparison
to total serum IgE (Fig. 2). There was
a significant difference (P <0.05) in the
geometric mean of total IgE between
JRA patients with positive (1420 IU/
mL) and negative (402 IU/mL) IgE-
RF. In contrast, no statistically signifi-
cant difference was found between
positive (157 IU/mL) and negative
(117 IU/mL) IgE-RF in the control
group (P >0.05). In addition, the mean
of total IgE values for JRA patients
Table 1 - Clinical and laboratory features of the children with juvenile rheumatoid arthritis (n= 91) according to disease
onset (systemic, pauciarticular, or polyarticular).
Clinical and Laboratory  Features JUVENILE RHEUMATOID ARTHRITIS
Total Systemic Pauciarticular Polyartycular
(n = 91) (n = 38) (n = 28) (n = 25)
Females 59 (64.4%) 21 (55,3%) 17 (60.71%) 21 (84%)
Age (years) 10.5 (2.1 – 22.7) 11 (4.1 – 20.8) 9.9 (2.4-17.2) 10.3 (4.2-18.6)
Disease duration (years) 5.2 (0.2– 17.3) 6.2 (1.1-13.6) 4.4 (0.7-10.2) 3.7 (0.2-11.6)
Age at onset (years) 5.2 (0.5 – 16.1) 4.7 (1.4-11.9) 5.5 (1.1-13.3) 6.7 (2.9-12.2)
Active disease 50 (55%) 21 (55.3%) 12 (42.8%) 17 (68%)
Erythrocyte sedimentation rate (>20 mm/h) 54 (59%) 26 (68.4%) 12 (42.8%) 16 (64%)
Anti nuclear antibody + 19 (21%) 1 (2.6%) 8 (28.6%) 10 (40%)
Rheumatoid factor (latex agglutination +) 5 (5.4%) ——— ———— 5 (20%)
Functional class (III/IV) 13 (14%) 11 (28.9%) ———— 2 (8%)
Radiological class (III/IV) 49 (54%) 26 (68.4%) 10 (35.7%) 13 (52%)
Elevated total serum IgE  (>300 IU/mL) 54  (59.3%) 26 (68.4%) 15 (53.6%) 13 (52%)
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Table 2 - Laboratory and clinical features among 15 patients with positive FR-IgE with juvenile rheumatoid arthritis (JRA)
and 76 patients with negative IgE-RF.
Laboratory and  Clinical Features Positive IgE-RF Negative IgE-RF P
      n (%)       n(%)       X2 or Fisher
Active disease 8 (53.3) 42 (55.3) NS
Erythrocyte sedimentation rate  (>20 mm/h) 7 (46.7) 47 (61.8) NS
Antinuclear antibody (+) 4 (26.7) 15 (19.7) NS
Rheumatoid factor (latex agglutination +) 2 (13.3) 3 (3.9) NS
Functional class (III/IV) 2 (13.3) 11 (14.5) NS
Radiological class (III/IV) 7 (46.7) 42 (55.3) NS
Log (geometric mean) of the total serum IgE 3.2* 2.2 P = 0.03
NS = Not significant.
with IgE-RF was higher than that ob-
tained for IgE-RF-positive control chil-
dren, although the difference was not
statistically significant (P = 0.055).
The geometric mean of total serum
IgE for all JRA patients (495 IU/mL)
was significantly higher than for the
control group (121 IU/mL), P <0.0001
(Fig 3).
DISCUSSION
The pathogenic role of the rheuma-
toid factor isotypes in JRA is not fully
understood14. The importance of the
IgM isotype detected by agglutination
methods is clear in terms of the classi-
fication and prognosis of this disease,
because this isotype defines the sero-
positive polyarticular subtype, and it
is related to progression to erosive dis-
ease4. However, few studies are avail-
able on other RF isotypes in JRA14.
Only 1 investigation assessing the
presence of IgE-RF in children with
JRA was found in the literature17.
Eleven out of 26 children studied
(42%) presented weakly positive reac-
tions (undiluted sera) for IgE-RF when
tested by indirect immunofluores-
cence17.
In our study, IgE-RF was detected
by ELISA in 15 (16.5%) of 91 children
with JRA, and this detection was not
Figure 1 - Levels of IgE-RF expressed in ELISA Index (EI). (A) Patients with JRA (n = 91) and
control children (n = 45). (B) JRA patients distributed according to the systemic (n = 38),
pauciarticular (n = 28), and polyarticular (n = 25) disease onset. The dashed line represents the
cut off of IgE-RF ELISA (EI >1).
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In our study, IgE-RF was detected
in 4 (8.9%) control children, and at
high concentrations in some of them,
indicating a low specificity of this an-
tibody. The children in this group were
considered healthy, with no clinical
history suggestive of atopy. However,
it should be emphasized that in the
patients with JRA studied here, the
presence of IgE-RF was correlated with
higher serum IgE concentrations,
whereas this was not observed in the
IgE-RF positive control group. These
data seem to indicate that the stimuli
responsible for IgE-RF production is
different in healthy individuals and in
patients with JRA.
The identification of IgE-RF in a
group of patients with JRA stimulates
the discussion of the role of this
autoantibody and consequently of the
IgE-dependent mechanisms involved in
the pathogenesis of this disease. The
prevalence of atopic disease in children
with JRA is unknown. It has been re-
ported that the incidence of IgE-spe-
cific antibodies against pollen allergens
in 40 children with JRA was similar to
that expected for the normal popula-
tion26. Some studies have suggested
that the prevalence of atopy among
adults with rheumatoid arthritis is equal
to or lower than that observed in the
normal population, although high con-
centrations of total serum IgE have been
detected in these patients14,26. Recently,
Millauer in 1999, comparing patients
with rheumatoid arthritis and patients
with allergic diseases, observed that
rheumatoid sera have high concentra-
tions of total serum IgE and complexed
anti-IgE, in addition to increased reac-
tivity of specific IgE against only 1 al-
lergen (Alternaria) and not against 9
other common allergens. Based on
these findings, the authors concluded
that the presence of large amounts of
IgE probably does not result in an in-
creased prevalence of allergic diseases
in patients with rheumatoid arthritis, as
previously mentioned14. On the other
Figure 2 - Levels of total serum IgE in JRA patients with positive IgE-RF (n = 15) and negative
IgE-RF (n = 76), and control children with positive IgE-RF (n= 4) and negative IgE-RF (n =
41). The horizontal bars indicate the geometric means.
Figure 3 - Levels of total serum IgE expressed in IU/mL in the group of JRA patients (n = 91)
and control children (n= 45). The horizontal bars indicate the geometric means.
related to the disease onset type. No
correlation was observed between the
presence of IgE-RF and any clinical or
laboratory parameter. Previous studies
have shown that low serum IgE-RF
concentrations are detected in approxi-
mately half the patients with rheuma-
toid arthritis, and high concentrations
are detected in patients with vasculi-
tis and other extra-articular manifesta-
tions and in patients with Felty’s syn-
drome15,16,25.
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hand, the presence of anti-IgE antibod-
ies seems to be paradoxical. According
to these authors, it is possible that anti-
IgE antibodies may interfere with IgE
binding, thus preventing the
sensitization of basophils and mast
cells34.
Some interesting studies have dem-
onstrated the presence of activated
mast cells in experimental rheumatoid
lesions27 and in synovial fluid of pa-
rheumatoid synovitis is uncertain.
In conclusion, IgE-RF can be de-
tected in some patients with JRA with
higher total serum IgE levels. We be-
lieve that the results reported here sug-
gest an alteration of the humoral im-
mune response in some children with
JRA and stimulate future research lines
aiming at the study of the IgE-depend-
ent biological mechanisms involved in
this disease.
tients with rheumatoid arthritis and
JRA28, the increased expression of the
CD23 antigen in peripheral mononu-
clear cells of patients with rheumatoid
arthritis29,30 and JRA31, and the repro-
duction of an experimental model of
arthritis by the inoculation of
monomeric or complexed IgE32,33.
However, the value of these findings
for the understanding of the physi-
opathological mechanisms involved in
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OBJETIVOS: Determinar os níveis
séricos do fator reumatóide-imuno-
globulina E na artrite reumatóide ju-
venil e correlacioná-los com parâ-
metros clínicos e laboratoriais.
MÉTODOS: Estudo multicêntrico
prospectivo, realizado entre janeiro de
1993 a janeiro de 1999 com participa-
ção de três centros de reumatologia
pediátrica. Estudaram-se 91 crianças
com o diagnóstico de artrite reumatóide
juvenil de acordo com os critérios do
Colégio Americano de Reumatologia:
38 (42%) com a forma de início
sistêmica, 28 (31%) pauciarticular e 25
(27%) poliarticular. A idade variou de
2,1 a 22,6 anos (média de 10,5 ± 4,7
anos) e 59 (65%) crianças eram do sexo
feminino. O grupo controle constituiu-
se de 45 crianças sadias. A detecção do
fator reumatóide-imunoglobulina E foi
realizada através de um ensaio
imunoenzimático. Associações do fator
reumatóide-imunoglobulina E  com: fa-
tor reumatóide-imunoglobulina M
(látex), imunoglobulina E sérica total,
VHS, FAN, classe funcional e radioló-
gica III ou IV foram analisadas.
RESULTADOS: Das 91 crianças
com artrite reumatóide juvenil, quinze
(16,5%) apresentaram fator reumatóide-
imunoglobulina E positivo. Destas,
7(18,5%) na forma sistêmica, 5 (18%)
na pauciarticular e 3 (12%) na
poliarticular. Observou-se correlação
estatisticamente significativa entre o
fator reumatóide-imunoglobulina E e a
média geométrica da imunoglobulina E
sérica total no total dos pacientes com
artrite reumatóide juvenil; não foi ob-
servada correlação estatística entre o fa-
tor reumatóide-imunoglobulina E e
positividade para o Látex, VHS, FAN e
classe funcional e radiológica 3 ou 4 em
nenhuma das formas de início da do-
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ença. Dos 45 controles, 4 (8,9%) tam-
bém apresentaram fator reumatóide-
imunoglobulina E positivo, mas não
houve correlação com a imunoglo-
bulina E sérica total.
CONCLUSÕES: O fator reuma-
tóide-imunoglobulina E pode ser detec-
tado em 16,5% dos pacientes com ar-
trite reumatóide juvenil, especialmen-
te naqueles com níveis elevados de
imunoglobulina E sérica total. O fator
reumatóide-imunoglobulina E parece
não se associar com atividade ou gra-
vidade da artrite reumatóide juvenil.
DESCRITORES: Fator Reuma-
tóide. Imunoglobulina E. Artrite
Reumatóide Juvenil. Ensaio imuno-
enzimático.
REFERENCES
1. SUTTON B, CORPER A, BONAGURA V et al. - The structure and
origin of rheumatoid factors. Immunol Today 2000; 21(4):
177-182.
2. TIGHE H & CARSON D A - Rheumatoid factor. In: KELLEY W
N, HARRIS Jr. E D, RUDDY S et al. - Textbook of
rheumatology. 5th ed. Philadelphia, Saunders, 1997. p. 241-
249.
3. PETTY RE, CASSIDY JT & SULLIVAN DB - Serologic studies in
juvenile rheumatoid arthritis: a review. Arthritis Rheum 1977;
20 (suppl.): 260.
4. SCHALLER JG - Juvenile rheumatoid arthritis.  Pediatr Rev 1997;
18 (10): 337-349.
5. EICHENFIELD AH, ATHREYA BH, DOUGHTY RA et al. - Utility
of rheumatoid factor in the diagnosis of juvenile rheumatoid
arthritis.  Pediatrics 1986; 78 (3): 480 - 483.
6. CASSIDY JT & PETTY RE - Juvenile rheumatoid arthritis. 3th
ed. Philadelphia, Saunder, 1995. p. 133-223.
7. ILOWITE NT, O‘REILLY ME,  HATAM L et al. - Expression of
the rheumatoid factor cross-reactive idiotype in JRA: association
with disease onset subtype, disease activity and disease severity.
Scand J Rheumatol 1992; 21: 51-54.
8. ILOWITE NT, WEDGWOOD JF & BONAGURA VR - Expression
of the major rheumatoid factor cross-reactive idiotype in juvenile
rheumatoid arthritis. Arthritis Rheum 1989; 32 (3): 265-270.
9. CASSIDY JT & VALKENBURG H A - A five year prospective
study of rheumatoid factor tests in juvenile rheumatoid arthritis.
Arthritis Rheum 1967; 10: 83-90.
10.WALKER SM, SHAHAM B, McCURDY DK et al. - Prevalence
and concentration of IgM rheumatoid factor in polyarticular
onset disease as compared to systemic or pauciarticular onset
disease in active juvenile rheumatoid arthritis as measured by
ELISA.  J Rheumatol 1990; 17 (7): 936-940.
11.JARVIS JN, POUSAK T & KRENZ M - Detection of IgM
rheumatoid factors by enzyme-linked immunosorbent assay in
children with juvenile rheumatoid arthritis: correlation with
articular disease and laboratory abnormalities.  Pediatrics 1992;
90 (6): 945-949.
12.WALKER SM, McCURDY DK, SHAHAM B et al. - High prevalence
of IgA rheumatoid factor in severe polyarticular-onset juvenile
rheumatoid arthritis, but not in systemic-onset or pauciarticular-
onset disease. Arthritis Rheum 1990; 33 (2): 199-204.
13.VARBANOVA BB, BALEVA M, NIKOLOV K et al. - Prevalence
of –IgM, -IgA and –IgG rheumatoid factors in seronegative
polyarticular disease compared to pauciarticular disease in
juvenile chronic arthritis as measured by ELISA. Adv Exp
Med Biol 1999; 455: 61-68.
14.MILLAUER N, ZUERCHER AW, MIESCHER SM et al. - High
IgE in rheumatoid arthritis (RA) patients is complexed with
anti-IgE autoantibodies.  Clin Exp Immunol 1999; 115 (1):
183-188.
15.MIZUSHIMA Y, SHOJI Y, HOSHI K et al. - Detection and clinical
significance of IgE rheumatoid factor.  J Rheumatol 1984; 11
(1): 22-26.
16.BURASTERO SE, LO PINTO G, GOLETTI D et al. - Rheumatoid
arthritis with monoclonal IgE rheumatoid factor.  J Rheumatol,
1993; 20 (3): 489-494.
3095.p65 30/10/02, 10:45215
216
REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(5):209-216, 2002 SEPTEMBER-OCTOBER
17.PERMIN G & EGESKJOLD EM - IgE anti-IgG antibodies in
patients with juvenile and adult rheumatoid arthritis including
Felty’s syndrome.  Allergy 1982; 37 (6): 421-427.
18.BREWER EJ, BASS J, BAUM J et al. - Current proposed revision
of JRA criteria. Arthritis Rheum 1977;  20 (2) (supll.): 195-
199.
19.POLLART SM, CHAPMAN MD, FIOCCO GP et al. - Epidemiology
of acute asthma: IgE antibodies to common inhalant allergens
as a risk factor for emergency room visits. J Allergy Clin
Immunol 1989; 83 (5): 875-882.
20.SILVA CHM - Contribuição para o estudo da imunoglobulina E
(IgE) sérica total em crianças com artrite reumatóide juvenil.
São Paulo, 1995. (Tese Doutorado em Pediatria - Faculdade de
Medicina da Universidade de São Paulo).
21.STEINBROCKER O, TRAEGER CH & BATTERMAN RE -
Therapeutic criteria in rheumatoid arthritis.  JAMA 1949; 140:
659-662.
22.SILVA CHM - Fator reumatóide IgM detectado pelo teste de fixação
do látex, reação de Waaler-Rose e ELISA em crianças com
artrite reumatóide juvenil. São Paulo, 1990. (Dissertação
Mestrado - Faculdade de Medicina, Universidade de São Paulo).
23.WILSON MB & NAKANE PK - Antibody conjugated to
horseradish peroxidase. In: KANPP K & NOLUBAR GW (Eds.)
- Immunofluorescence and related staining technique.
Amsterdam, Elsevier Norths Holland Biomedical, 1978. p. 215-
224.
24.TRIOLA  MF -  Introdução à estatística.  7ª. ed. Rio de Janeiro,
LTC (Livro Técnico e Científico E.S.A.), 1999.
25.MERETEY K, FALUS A, BÖHM U et al. - IgE class immune
complexes in Felty’s syndrome: characterisation of antibody
activities in isolated complexes. Ann Rheum Dis 1984; 43 :
246-250.
26.PESKETT SA,  PLATTS-MILLS TAE, ANSELL BM et al. -
Incidence of atopy in rheumatic disease.  J Rheumatol 1981;
8 (2): 321-324.
27.CAULFIELD JP, HEIN A, HELFGOTT SM et al. - Intraarticular
injection of arthritogenic factor causes mast cell degranulation,
inflammation, fat necrosis, and synovial hyperplasia.  Lab Invest
1988; 59 (1): 82-95.
28.GRUBER B, BALLAN D & GOREVIC PD - IgE rheumatoid
factors: quantification in synovial fluid and ability to induce
synovial mast cell histamine release.  Clin Exp Immunol 1988;
71 (2): 289-294.
29.CHOMARAT P, BRIOLAY J, BANCHEREAU J et al. - Increased
production of soluble CD23 in rheumatoid arthritis, and its
regulation by interleukin-4. Arthritis Rheum 1993; 36 (2):
234-242.
30.FERNÁNDEZ-GUTIÉRREZ B, HERNÁNDEZ-GARCÍA C,
BAÑARES AA et al. -  CD23 hyperexpression in rheumatoid
arthritis: evidence for a B cell hyperresponsiveness to cognate
and noncognate T-cell signals.  Clin Immunol Immunopathol
1994; 72 (3): 321-327.
31.MASSA M,  PIGNATTI P, OLIVERI M et al. - Serum soluble
CD23 levels and CD23 expression on peripheral blood
mononuclear cells in juvenile chronic arthritis.  Clin Exp
Rheumatol 1998; 16 (5) : 611-616.
32.DE CLERCK LS, STRUYF NJ & STEVENS, WJ - Activation of
inflammatory cells by immune complexes containing IgE in
serum and synovial fluid of patients with rheumatoid arthritis:
a study using flow cytometric analysis. Ann Rheum Dis 1991;
50: 379-382.
33.DE CLERCK LS, STRUYF NJ, BRIDTS C H et al. - Experimental
arthritis in rats induced by intra-articular injection of IgE
aggregates: evidence of arthritogenic role of complexed IgE.
Ann Rheum Dis 1992; 51: 210 - 213.
34.GRUBER BL - Immunoglobulin E, mast cells, endogenous
antigens, and arthritis.  Rheum Dis Clin North Am, 1991; 17
(2): 333-342.
Received for publication on March 13, 2002.
3095.p65 30/10/02, 10:45216
